Introduction to the PTBD procedure

The PTBD procedure stands as a fundamental intervention in hepatobiliary interventional radiology, providing life-saving biliary decompression when endoscopic approaches are anatomically impossible or clinically insufficient. Percutaneous transhepatic biliary drainage involves the ultrasound or fluoroscopy-guided puncture of dilated intrahepatic bile ducts, followed by wire exchange and catheter placement to establish external or internal-external biliary flow. This evidence-based guide equips interventional radiologists, radiographers, and hospital administrators with a comprehensive protocol for safe and effective PTBD procedure execution across malignant, benign, and infectious biliary pathologies.

Pathophysiology of biliary obstruction

Mechanisms of biliary obstruction

Biliary obstruction arises from intrinsic luminal narrowing, extrinsic compression, or intraluminal occlusion of the biliary tree. Malignant causes include hilar cholangiocarcinoma (Klatskin tumor), pancreatic head adenocarcinoma, gallbladder carcinoma, and metastatic lymphadenopathy. Benign etiologies encompass post-surgical anastomotic strictures, chronic pancreatitis with fibrotic duct compression, primary sclerosing cholangitis (PSC), and choledocholithiasis. Regardless of cause, proximal biliary obstruction that may eventually require the PTBD procedure leads to intrahepatic ductal dilation, cholestasis, hepatocyte injury, and progressive fibrosis if left untreated.

Consequences of untreated obstruction

Prolonged biliary obstruction results in direct bilirubin elevation, impaired bile acid enterohepatic circulation, fat-soluble vitamin malabsorption, and portal tract inflammation. In the setting of bacterial colonization, ascending cholangitis develops with Charcot triad (fever, jaundice, right upper quadrant pain) or Reynolds pentad (Charcot triad plus hypotension and altered mental status). The PTBD procedure interrupts this pathophysiologic cascade by restoring bile flow, decompressing the obstructed system, and facilitating definitive therapy whether surgical, endoscopic, or percutaneous.^[1,2]

Indications and patient selection

Malignant biliary obstruction

The most common indication for the PTBD procedure is malignant biliary obstruction when endoscopic retrograde cholangiopancreatography (ERCP) fails or is anatomically precluded. Hilar cholangiocarcinoma (Bismuth-Corlette types III and IV) frequently requires bilateral PTBD because endoscopic bilateral stenting carries high failure rates.^[3,4] Pancreatic head cancers causing distal obstruction may undergo PTBD when duodenal invasion prevents endoscope passage. Preoperative biliary drainage before major hepatectomy is indicated when total bilirubin exceeds 10 mg/dL and extended liver resection is planned, as hyperbilirubinemia impairs hepatocyte regeneration and increases postoperative morbidity.^[5,6]

Benign biliary strictures

Benign indications for the PTBD procedure include post-surgical anastomotic strictures following liver transplantation, hepaticojejunostomy, or choledochojejunostomy. Chronic pancreatitis with distal common bile duct stricture may require temporary PTBD to relieve jaundice before definitive surgical or endoscopic therapy. Primary sclerosing cholangitis with dominant strictures benefits from balloon dilation via the percutaneous route when endoscopic access is limited. Choledocholithiasis with failed ERCP extraction represents another accepted indication, particularly when percutaneous transhepatic cholangioscopy and lithotripsy are planned.^[7,8]

Acute cholangitis and biliary sepsis

Acute cholangitis with failed endoscopic drainage constitutes an urgent indication for the PTBD procedure. The Tokyo Guidelines 2018 (TG18) classify cholangitis severity into grades I, II, and III, with grade III (organ dysfunction) requiring emergent biliary decompression.^[9] Percutaneous drainage offers rapid source control when ERCP is unavailable, technically unsuccessful, or contraindicated by hemodynamic instability. In patients with prior Roux-en-Y hepaticojejunostomy or Whipple anatomy, the PTBD procedure often represents the only feasible drainage route.^[10]

Contraindications and risk stratification

Absolute and relative contraindications

Absolute contraindications to the PTBD procedure include uncorrectable coagulopathy (INR >1.5, platelets <50,000/μL), massive ascites without pre-procedural drainage, and non-dilated intrahepatic bile ducts without a safe percutaneous window. Relative contraindications encompass multiple scattered intrahepatic stones without ductal dilation, uncorrectable electrolyte disturbances, and severe cardiopulmonary compromise preventing prone or lateral positioning. Polycystic liver disease increases hemorrhage risk due to intervening cysts. For patients with ascites, a pre-procedural paracentesis or left-sided subxiphoid approach may mitigate risk.^[11,12]

Pre-procedural risk assessment

Risk stratification before the PTBD procedure incorporates the Child-Pugh score, MELD-Na score, and assessment of sepsis severity. Patients with Child-Pugh C cirrhosis face higher bleeding risk due to coagulopathy and thrombocytopenia. Pre-procedural correction with fresh frozen plasma, platelets, and vitamin K is essential. For patients with suspected cholangitis, hemodynamic stability must be achieved before proceeding, with vasopressor support and broad-spectrum antibiotics initiated in the intensive care unit when necessary.^[13]

Pre-procedural evaluation and imaging

Laboratory workup

Essential laboratory investigations before the PTBD procedure include complete blood count, comprehensive metabolic panel with liver function tests, coagulation profile (INR, aPTT, fibrinogen), type and screen, and blood cultures if cholangitis is suspected. Serum bilirubin levels guide the urgency of drainage, while alkaline phosphatase and gamma-glutamyl transferase confirm cholestatic pathology. Prothrombin time should be corrected to INR <1.5 with vitamin K and fresh frozen plasma. Platelet transfusion is indicated for counts <50,000/μL.^[14]

Cross-sectional imaging

Contrast-enhanced CT or MRI with MRCP is mandatory before the PTBD procedure to define the level and cause of obstruction, assess ductal dilation, identify vascular relationships, and classify hilar tumors using the Bismuth-Corlette system. CT evaluates for portal vein encasement, hepatic artery involvement, and metastatic disease. MRI with MRCP provides superior soft-tissue contrast for hilar cholangiocarcinoma and defines the extent of intrahepatic ductal involvement. For preoperative drainage, CT volumetry calculates future liver remnant volume to guide the extent of required drainage.^[15,16]

Antibiotic prophylaxis

Broad-spectrum intravenous antibiotics covering gram-negative enteric organisms and anaerobes should be administered 60 minutes before skin incision. Recommended regimens include piperacillin-tazobactam 3.375 g IV or ceftriaxone 2 g IV plus metronidazole 500 mg IV. For patients with healthcare-associated infections or prior biliary instrumentation, coverage should be extended based on local antibiogram data and prior culture results.^[9,17]

Step-by-step PTBD procedure technique

Patient positioning and access planning

The PTBD procedure is performed under conscious sedation or general anesthesia depending on patient tolerance and procedural complexity. The patient is positioned supine with the right side elevated 15–20 degrees for right intercostal approaches. The right intercostal approach via the 10th or 11th intercostal space in the mid-axillary line is preferred for right lobe duct access. The left subxiphoid or subcostal approach is used for left lobe drainage, particularly when right lobe ducts are nondilated or when the left approach avoids pleural transgression. Ultrasound is used to mark the skin entry site, avoiding the pleural reflection, lung bases, and colon.^[18,19]

Initial puncture and cholangiography

During the PTBD procedure, real-time ultrasound guidance directs the 21G Chiba needle into a dilated peripheral intrahepatic duct. Aspirated bile confirms intraductal position. A small volume (5–10 mL) of diluted non-ionic contrast (1:1 with normal saline) is injected slowly under fluoroscopy to obtain a percutaneous transhepatic cholangiogram (PTC). If cholangitis is suspected, 20–30 mL of bile should be aspirated before contrast injection to reduce bacteremia and sepsis risk. The PTC defines the anatomy, identifies the obstruction level, and guides subsequent wire and catheter manipulation.^[20,21]

Wire exchange and tract dilation

After confirming intraductal position, a 0.018-inch mandril wire is advanced through the Chiba needle into the ductal system. The needle is exchanged for a 4F or 5F transitional dilator, and the 0.018-inch wire is exchanged for a 0.035-inch hydrophilic guidewire (Glidewire). The wire is advanced past the stricture into the duodenum for internal-external drainage, or coiled within the dilated duct for external drainage alone. The tract is dilated to accommodate the final drainage catheter, typically 8F to 10F for external drainage or 10F to 12F for internal-external stent placement.^[22,23]

Catheter placement and fixation

A locking pigtail catheter with multiple side holes is advanced over the stiff wire into the desired position. For external drainage, the catheter tip is positioned centrally within the dilated ductal system proximal to the obstruction. For internal-external drainage, the catheter traverses the stricture with the pigtail in the duodenum and side holes straddling the obstruction. The catheter is locked, connected to a drainage bag, and secured to the skin with sutures and an occlusive dressing. A post-procedure cholangiogram through the catheter confirms optimal position and excludes extravasation.^[24]

Equipment and consumables

Needles, wires, and catheters

The PTBD procedure requires a 21G Chiba needle (15 cm length) for initial puncture, a 0.018-inch mandril wire, and a 4F transitional dilator for wire exchange. A 0.035-inch hydrophilic guidewire facilitates navigation through tortuous ducts and strictures, while a 0.035-inch stiff Amplatz wire provides support for catheter exchanges. The drainage catheter is typically an 8F to 10F locking pigtail catheter with 8–12 side holes. For internal-external drainage, a 10F to 12F biliary drainage catheter with an end-hole and side holes is preferred.^[25]

Imaging equipment

Real-time ultrasound guidance (3.5–5 MHz curvilinear probe) is essential for initial needle placement and duct visualization. Fluoroscopy with digital subtraction angiography (DSA) at 2–3 frames per second is used for cholangiography, wire manipulation, and catheter deployment. C-arm CT or cone-beam CT may be employed for complex hilar anatomy or when standard fluoroscopic views are insufficient. For patients with non-dilated ducts, CT fluoroscopy provides superior visualization and may be the only safe guidance modality.^[26]

Contrast media and flow parameters

Contrast selection and dilution

Non-ionic iodinated contrast media (Visipaque 320 or Omnipaque 350) diluted 1:1 with normal saline is used for cholangiography during the PTBD procedure. Dilution prevents excessive hyperosmolar load and reduces the risk of contrast-induced nephropathy in patients with pre-existing renal dysfunction. Total contrast volume should be minimized, particularly in patients with cholangitis, to avoid bacteremia and hemodynamic instability.^[27]

Injection parameters

Initial PTC injection: 5–10 mL total at 1–2 mL/s by hand. Selective cholangiogram through the drainage catheter: 10–20 mL at 2–3 mL/s. For internal-external stent deployment, no contrast is injected during balloon inflation. Post-procedure tube check cholangiogram: 10–20 mL of diluted contrast at 1–2 mL/s to assess catheter position, drainage adequacy, and residual filling defects.^[28]

Internal-external drainage and stenting

Internal-external versus external drainage

Internal-external drainage is preferred over external drainage alone because it allows bile to enter the duodenum, preserving enterohepatic circulation and reducing electrolyte and fluid losses. The catheter traverses the stricture with the pigtail in the duodenum and side holes proximal to the obstruction. External drainage alone is reserved for patients with complete distal obstruction, duodenal invasion preventing catheter passage, or when the PTBD procedure is performed as a temporary bridge to surgery.^[29]

Metal stent placement

For patients undergoing the PTBD procedure with malignant biliary obstruction and expected survival >3 months, self-expanding metal stents (SEMS) provide superior long-term patency compared to plastic stents. SEMS are deployed percutaneously through a mature tract or during the index PTBD procedure if the stricture is traversable and the patient is hemodynamically stable. Covered SEMS (ePTFE or polyurethane) reduce tumor ingrowth but carry higher migration risk. Uncovered SEMS are preferred for hilar strictures to avoid side-branch occlusion. For benign strictures, balloon dilation with temporary plastic stenting is preferred over permanent metal stent placement.^[30,31]

Post-procedural care and catheter management

Immediate post-procedure monitoring

After the PTBD procedure, patients are monitored for hemorrhage, bile peritonitis, and sepsis. Vital signs are assessed every 15 minutes for the first hour, then every 30 minutes for 4 hours. The drainage bag is inspected for bile color, volume, and presence of blood. Post-procedure antibiotics are continued for 48–72 hours in patients with cholangitis. Pain is managed with acetaminophen; nonsteroidal anti-inflammatory drugs are avoided due to bleeding risk and renal impairment.^[32]

Catheter flushing and maintenance

The PTBD catheter requires daily flushing with 10 mL of normal saline to maintain patency and prevent sludge accumulation. The drainage bag is emptied and measured daily. The catheter should never be clamped unless a tube check cholangiogram confirms internal drainage without residual obstruction. If output decreases or stops, the catheter should be flushed gently; if resistance is met, a tube check cholangiogram is performed to evaluate for displacement, kinking, or clogging.^[33]

Patient education

Patients and caregivers receive comprehensive education on catheter care before discharge. Instructions include daily flushing technique, signs of infection (fever, chills, purulent drainage), signs of dislodgement (decreased output, bile leak around catheter), and emergency contact protocols. Patients should avoid swimming or submerging the catheter site and should secure the drainage bag below the level of the liver to maintain gravity-dependent drainage.^[34]

Complications and their management

Sepsis and cholangitis

Sepsis after the PTBD procedure occurs in 10–20% of cases, most commonly from undrained segments or forceful contrast injection in infected systems. Clinical presentation includes fever, tachycardia, hypotension, and altered mental status within 24 hours. Management includes blood and bile cultures, broad-spectrum antibiotic escalation, hemodynamic support, and urgent imaging to identify undrained segments. If undrained segments are identified, additional PTBD catheters may be required.^[35]

Hemorrhage and hemobilia

Hemorrhage complicates the PTBD procedure in 3–5% of cases, ranging from minor catheter tract oozing to life-threatening hemobilia or intraperitoneal hemorrhage. Hemobilia presents with the classic Quincke triad: jaundice, right upper quadrant pain, and gastrointestinal bleeding. Management includes correction of coagulopathy, transfusion of blood products, and emergent angiography with selective arterial embolization of the offending vessel (typically a branch of the hepatic artery).^[36]

Pleural injury and pneumothorax

The right intercostal approach risks pleural transgression with pneumothorax or hemothorax, particularly when needle placement is above the 10th intercostal space or too medial. A post-procedure chest radiograph is recommended after right-sided PTBD. Small asymptomatic pneumothoraces may be observed, while larger or symptomatic collections require chest tube drainage. The risk is minimized by staying below the 12th rib and using ultrasound to identify the pleural reflection.^[37]

Bile peritonitis and leakage

Bile peritonitis results from extravasation during needle passes or catheter dislodgement. Clinical signs include peritoneal irritation, fever, and leukocytosis. Prevention involves meticulous technique, limiting needle passes, and confirming intraductal position before contrast injection. If bile peritonitis occurs, percutaneous drainage of the biloma and broad-spectrum antibiotics are required. Catheter dislodgement occurs in 10–15% of long-term catheters and may require repeat PTBD if the tract has not matured.^[38]

Tumor seeding

Tumor seeding along the PTBD tract occurs in 2–5% of patients with cholangiocarcinoma, typically manifesting as a painful subcutaneous nodule months after catheter removal. This complication is unique to percutaneous approaches and does not occur with endoscopic drainage. Prevention strategies include minimizing tract manipulations and considering prophylactic tract irradiation in high-risk patients. If seeding occurs, wide local excision with clear margins is the treatment of choice.^[39]

Follow-up protocols and catheter exchange

Tube check cholangiography

A tube check cholangiogram is performed 7–14 days after the PTBD procedure to assess drainage adequacy, catheter position, and resolution of obstruction. The procedure involves gentle injection of 10–20 mL of diluted contrast through the catheter under fluoroscopy. If contrast flows freely into the duodenum without residual filling defects, the catheter may be capped for a trial of internal drainage. If persistent obstruction or sludge is identified, catheter flushing or exchange is performed.^[40]

Catheter exchange schedule

Plastic biliary catheters placed during the PTBD procedure require exchange every 2–3 months to prevent occlusion from proteinaceous debris and bacterial biofilm. Exchange is performed over a guidewire through the mature tract, typically as an outpatient procedure. Metal stents do not require routine exchange but need surveillance with ultrasound or CT every 2–3 months for occlusion. If metal stent occlusion occurs, a new stent may be placed through the existing lumen or a percutaneous drainage catheter may be required.^[41,42]

Long-term surveillance

For patients with malignant obstruction, CT or MRI every 2–3 months assesses disease progression, stent patency, and the development of new strictures. For benign strictures, clinical and laboratory monitoring (bilirubin, alkaline phosphatase, GGT) every 3 months is sufficient. If stenosis recurs after balloon dilation, repeat dilation or prolonged plastic stenting may be required. Patients awaiting liver transplantation require coordinated surveillance to ensure biliary drainage is maintained until graft availability.^[43]

Conclusion

The PTBD procedure remains an indispensable intervention for biliary decompression when endoscopic therapy is impossible or insufficient. Success with the PTBD procedure depends on meticulous patient selection, precise ultrasound-guided puncture technique, and rigorous post-procedural catheter management. Interventional radiology teams must maintain proficiency in Chiba needle placement, wire navigation through complex biliary anatomy, and recognition of early complications including sepsis and hemorrhage. As metal stent technology advances and multidisciplinary hepatobiliary care models mature, the PTBD procedure continues to serve as both a life-saving emergency intervention and a bridge to definitive surgical or oncologic therapy.